Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Navidea Biopharmaceuticals Inc (NAVB) Upgraded to "Buy" by Zacks Investment Research

 

Navidea Biopharmaceuticals Inc (NAVB) Upgraded to "Buy" by Zacks Investment Research

2016-04-09 14:25:16| Biotech - Topix.net

The firm presently has a $1.25 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target suggests a potential upside of 9.65% from the company's previous close.

Tags: buy research investment upgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	23.11 23.11 WEEZER / maladroit 12\" 23.11 23.11 6'1ML REV-S 23.11 speak up storys 23.11 190mm LS0713FL 23.11 That's Moulton 23.11 SEED More »